全文获取类型
收费全文 | 159782篇 |
免费 | 10028篇 |
国内免费 | 1232篇 |
专业分类
耳鼻咽喉 | 2453篇 |
儿科学 | 2700篇 |
妇产科学 | 2628篇 |
基础医学 | 25117篇 |
口腔科学 | 3643篇 |
临床医学 | 15146篇 |
内科学 | 29203篇 |
皮肤病学 | 4812篇 |
神经病学 | 13451篇 |
特种医学 | 8665篇 |
外科学 | 20722篇 |
综合类 | 1013篇 |
现状与发展 | 4篇 |
一般理论 | 39篇 |
预防医学 | 9423篇 |
眼科学 | 4113篇 |
药学 | 13982篇 |
中国医学 | 1572篇 |
肿瘤学 | 12356篇 |
出版年
2023年 | 1078篇 |
2022年 | 3084篇 |
2021年 | 5053篇 |
2020年 | 2496篇 |
2019年 | 3559篇 |
2018年 | 4367篇 |
2017年 | 3514篇 |
2016年 | 4574篇 |
2015年 | 6263篇 |
2014年 | 7479篇 |
2013年 | 8849篇 |
2012年 | 13229篇 |
2011年 | 12651篇 |
2010年 | 7298篇 |
2009年 | 6306篇 |
2008年 | 9031篇 |
2007年 | 8771篇 |
2006年 | 7927篇 |
2005年 | 7414篇 |
2004年 | 6544篇 |
2003年 | 5763篇 |
2002年 | 5063篇 |
2001年 | 3949篇 |
2000年 | 3662篇 |
1999年 | 2885篇 |
1998年 | 1222篇 |
1997年 | 971篇 |
1996年 | 772篇 |
1995年 | 720篇 |
1994年 | 604篇 |
1993年 | 576篇 |
1992年 | 1331篇 |
1991年 | 1305篇 |
1990年 | 1159篇 |
1989年 | 1124篇 |
1988年 | 1033篇 |
1987年 | 1032篇 |
1986年 | 818篇 |
1985年 | 859篇 |
1984年 | 646篇 |
1983年 | 513篇 |
1982年 | 372篇 |
1981年 | 381篇 |
1980年 | 322篇 |
1979年 | 517篇 |
1978年 | 416篇 |
1977年 | 300篇 |
1976年 | 289篇 |
1974年 | 335篇 |
1973年 | 336篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell. 总被引:1,自引:0,他引:1
Beta-adrenergic receptor density on T cells from healthy humans is greatest on suppressor cells (CD8+, CD28-) and the effect of catecholamines, secreted by the sympathetic nervous system, predominates on this subset. The sympathetic skin response, a measure of sympathetic nervous system function, is absent in most patients with chronic progressive multiple sclerosis (MS). We measured beta-adrenergic receptor density on suppressor cells, cytotoxic cells, and monocytes from patients with chronic progressive MS and healthy control subjects. Control receptor density on suppressor cells was 2.8 +/- 0.3 fmol/10(6) cells versus a density of 5.1 +/- 0.7 fmol/10(6) cells for patients. Cytotoxic cell (CD8+, CD28+) receptor density was 1.4 +/- 0.4 fmol/10(6) cells in control subjects and 0.9 +/- 0.3 fmol/10(6) cells in the patients. Monocytes displayed beta-adrenergic receptor densities of 2.6 +/- 0.4 fmol/10(6) cells in normal individuals and 2.7 +/- 0.4 fmol/10(6) cells in the patient group. CD8 lymphocyte beta-adrenergic receptor densities in patients with relapsing-remitting and those with stable MS were not different from control values, yet were significantly less than the values for patients with chronic progressive MS. We find that mononuclear cells from healthy control subjects and patients with chronic progressive MS proliferate in response to 200 units/ml of recombinant human interleukin-2 (IL-2) similarly. However, IL-2 treatment increased beta-adrenergic receptor density on normal mononuclear cells, but failed to increase it on mononuclear cells from patients with chronic progressive MS.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
102.
103.
104.
J H Newcorn J M Halperin J M Healey J D O'Brien D M Pascualvaca L E Wolf A Morganstein V Sharma J G Young 《Journal of the American Academy of Child and Adolescent Psychiatry》1989,28(5):734-738
To assess the relationship between the DSM-III criteria for attention deficit disorder with hyperactivity (ADDH) and the DSM-III-R criteria for attention-deficit hyperactivity disorder (ADHD), children from an inner city parochial school were evaluated using a 30-item teacher questionnaire consisting of the DMS-III and DSM-III-R criteria for these disorders, the revised Conners Parent and Teacher Questionnaires, and a continuous performance test. Diagnostic groups were established based on teacher ratings of the DSM items and evaluated in relation to the rating scale data and continuous performance test. While children who were identified by teachers as having ADDH almost always satisfied the criteria for ADHD, a new group of children who were hyperactive and impulsive but less clearly inattentive also met the criteria for ADHD. Implications of the change in diagnostic criteria are discussed. 相似文献
105.
106.
Taylor Moran-Gates Christopher Grady Young Shik Park Ross J Baldessarini Frank I Tarazi 《European neuropsychopharmacology》2007,17(6-7):448-455
The atypical antipsychotic risperidone is often prescribed to pediatric patients with neuropsychiatric disorders, though its effects on the developing brain remain unclear. Accordingly, we studied the effects of repeated treatment of risperidone on dopamine receptors in brain regions of juvenile rat. Levels of dopamine receptors (D(1), D(2), D(3), D(4)) in forebrain regions of juvenile rats were quantified after 3 weeks of treatment with three different doses of risperidone (0.3, 1.0 and 3.0 mg/kg) and compared findings to those in adult rats treated with risperidone (3.0 mg/kg/day) previously. Risperidone (at 1.0 and 3.0 mg/kg/day) increased levels of D(1) receptors in nucleus accumbens and caudate-putamen of juvenile, but not adult rats. Conversely, all three doses of risperidone dose-dependently increased D(2) labeling in medial prefrontal cortex and hippocampus, and D(4) receptor in nucleus accumbens, caudate-putamen and hippocampus of juvenile animals as well as in adults. Only the high dose of risperidone (3.0 mg/kg) increased D(2) receptors in caudate-putamen in both juvenile and adult brain. D(3) receptors were not altered by risperidone in any brain region at any dose or age. The findings indicate dose-dependent effects of risperidone on dopamine receptors in developing animals, and that juvenile animals are more sensitive than adults to the cerebral effects of risperidone. 相似文献
107.
108.
109.
110.